Dr. Erkan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 E 70th St
New York, NY 10021Phone+1 212-774-2291Fax+1 212-774-2374
Summary
- Dr. Doruk Erkan, based in New York, NY, specializes in rheumatology with a focus on lupus erythematosus, systemic lupus erythematosus, mixed connective tissue disease, and arthritis. He completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai/Beth Israel and graduated from Hacettepe University FOM. Dr. Erkan has published extensively on antiphospholipid syndrome and lupus. His research involves several clinical trials, including studies on medications like MMF, hydroxychloroquine, and fluvastatin for patients with lupus and antiphospholipid syndrome. He has also been recognized as a Fellow by the American College of Rheumatology.
Education & Training
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1995 - 1998
Hacettepe University FOMClass of 1995
Certifications & Licensure
NY State Medical License 2001 - 2025
FL State Medical License 2012 - 2014
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome Start of enrollment: 2007 Sep 01
- Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients Start of enrollment: 2008 May 01
- Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and Internation...Yasaman Ahmadzadeh, Laurence S Magder, Danieli Castro Oliveira de Andrade, Diana Paredes-Ruiz, Maria G Tektonidou
Arthritis Care & Research. 2025-02-02 - An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee...Katrien M J Devreese, Maria Laura Bertolaccini, D Ware Branch, Bas de Laat, Doruk Erkan
Journal of Thrombosis and Haemostasis. 2025-02-01 - Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) "Damage" workin...Gustavo G M Balbi, Pedro Gaspar, Hannah Cohen, David A Isenberg, Doruk Erkan
Seminars in Arthritis and Rheumatism. 2025-02-01
Journal Articles
- Factors Associated with First Thrombosis in Patients Presenting with Obstetric Antiphospholipid Syndrome in APS Alliance for Clinical Trials & International Networking...Doruk Erkan, Michelle Petri, H Michael Belmont, Jason S Knight, BJOG: An International Journal of Obstetrics & Gynaecology
Lectures
- New Diagnostic and Treatment Strategies for Antiphospholipid Syndrome61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Other
- McMaster RARE‐Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid SyndromeDoruk Erkan, MD, Journal of Thrombosis and Haemostasis
https://www.doximity.com/articles/8ab28beb-5bfe-44a8-acbc-c9ce9270ef68
UpToDate, Wolters Kluwer Health - 2012-07-26 - McMaster RARE‐Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid SyndromeDoruk Erkan, MD, Journal of Thrombosis and Haemostasis
https://www.doximity.com/articles/8ab28beb-5bfe-44a8-acbc-c9ce9270ef68
UpToDate, Wolters Kluwer Health - 2012-08-13
Press Mentions
Novel Anti-NET Antibodies in a Multinational CohortMarch 28th, 2023- Updates on the ACR/EULAR Antiphospholipid SyndromeDecember 12th, 2022
- Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid SyndromeAugust 3rd, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
